TYPHOID VI POLYSACCHARIDE VACCINE, PRESER

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9822 to DMS PHARMACEUTICAL GROUP INC, with CAGE code 1UNB0, for the supply of 360 units of TYPHOID VI POLYSACCHARIDE VACCINE, PRESER, identified by NSN 6505015334962 and NDC 49281-0790-51, at a total contract price of $26,676.00. The award, issued on July 15, 2026, is firm-fixed-price with no option quantities or variance allowances, and performance is limited to a single delivery scheduled for the same date. Shipment is to be delivered FOB destination to the USS JASON DUNHAM at FPO AE 09567, with the contractor bearing all costs and risks until arrival. Upon delivery, the Government conducts inspection and acceptance at the destination. All packaging must comply with DLAD PROC NOTES C19 and C20, prohibit parcel post, and be marked with contract identification numbers from Blocks 1 and 2, including the CAGE code 7V915 and NDC. The vaccine, classified as a preserved biological product, requires appropriate handling, though specific preservation methods are not detailed. Payment is processed through DEF FIN AND ACCOUNTING SVC in Columbus, Ohio, via traditional voucher systems referencing D.O. Voucher, S/R Voucher, and Bill of Lading numbers, with no indication of electronic invoicing systems. The awardee is certified as a Small Disadvantaged Women-Owned Business, triggering compliance with FAR 19.13 and DFARS 219.13 requirements, including SAM.gov registration and potential post-award verification. The contracting officer is LISA QUINN, reachable at LISA.QUINN@DLA.MIL, with JAYNE DO serving as an administrative contact at DLA Troop Support. The contract does not include explicit FAR clauses, special requirements, evaluation factors, or referenced military standards, and no attachments or Section H provisions are present in the available documentation.